L-DOPS, >=98% (HPLC)

L-DOPS, >=98% (HPLC)

Application

L-DOPS has been administered for clinical trial studies in mice with amyloid pathology.

Biochem/physiol Actions

L-DOPS is a norepinephrine precursor in vivo.

Features and Benefits

This compound is featured on the Dopamine, Norepinephrine and Epinephrine Synthesis page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

General description

L-DOPS, also called L-threo 3,4-Dihydroxyphenylserine or droxidopa is a catecholamine. L-DOPS has many clinical advantages and may be useful for treating norepinephrine deficiency. It is used for treating neurogenic orthostatic hypotension and improves norepinephrine levels. L-DOPS mediates reduction of amyloid plaques and could have a therapeutic potential for treating amyloid pathology.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573342 L-DOPS, >=98% (HPLC) white to tan 100 QXWYKJLNLSIPIN-JGVFFNPUSA-N 1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1 SIGMA-ALDRICH powder ≥98% (HPLC)
£717.32 (exc VAT) per 25MG
-
+
3573343 L-DOPS, >=98% (HPLC) white to tan 100 QXWYKJLNLSIPIN-JGVFFNPUSA-N 1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1 SIGMA-ALDRICH powder ≥98% (HPLC)
£179.68 (exc VAT) per 5MG
-
+